scholarly journals Targeting the TGFβ pathway in uterine carcinosarcoma

Cell Stress ◽  
2020 ◽  
Vol 4 (11) ◽  
pp. 252-260
Author(s):  
Shailendra Kumar Dhar Dwivedi ◽  
Geeta Rao ◽  
Anindya Dey ◽  
Megan Buechel ◽  
Yushan Zhang ◽  
...  
Keyword(s):  
Growth Factor ◽  
Epithelial To Mesenchymal Transition ◽  
Transforming Growth Factor ◽  
Kinase Inhibitor ◽  
3D Culture ◽  
Transforming Growth Factor Β ◽  
Uterine Carcinosarcoma ◽  
Mesenchymal Transition

Uterine carcinosarcoma (UCS) is a relatively infrequent, but extremely aggressive endometrial malignancy. Although surgery and chemotherapy have improved outcomes, overall survival (OS) remains dismal due to the lack of targeted therapy and biphasic (epithelial and mesenchymal) nature that renders the tumor aggressive and difficult to manage. Here we report a role of transforming growth factor-β (TGFβ) in maintaining epithelial to mesenchymal transition (EMT) phenotype and aggressiveness in UCS. Using a 3D-culture system, we evaluated the efficacy of the transforming growth factor-β receptor-I (TGFβR1) kinase inhibitor Galunisertib (GLT), alone and in combination with standard chemotherapeutic drugs used for the management of UCS. We demonstrate that GLT by inhibiting canonical and non-canonical signaling emanating from transforming growth factor-β1 (TGFβ1) reduces cellular viability, invasion, clonal growth and differentiation. Interestingly, GLT sensitizes UCS cells to chemotherapy both in vitro and in in vivo preclinical tumor model. Hence, targeting TGFβ signaling, in combination with standard chemotherapy, may be exploited as an important strategy to manage the clinically challenging UCS.

scholarly journals Tenascin-X promotes epithelial-to-mesenchymal transition by activating latent TGF-β

2014 ◽  
Vol 205 (3) ◽  
pp. 409-428 ◽  
Author(s):  
Lindsay B. Alcaraz ◽  
Jean-Yves Exposito ◽  
Nicolas Chuvin ◽  
Roxane M. Pommier ◽  
Caroline Cluzel ◽  
...  
Keyword(s):  
Epithelial To Mesenchymal Transition ◽  
Transforming Growth Factor ◽  
Mammary Epithelial Cells ◽  
Noncovalent Interactions ◽  
Transforming Growth Factor Β ◽  
Cell Surface Receptor ◽  
Mesenchymal Transition ◽  
Surface Receptor

Transforming growth factor β (TGF-β) isoforms are secreted as inactive complexes formed through noncovalent interactions between the bioactive TGF-β entity and its N-terminal latency-associated peptide prodomain. Extracellular activation of the latent TGF-β complex is a crucial step in the regulation of TGF-β function for tissue homeostasis. We show that the fibrinogen-like (FBG) domain of the matrix glycoprotein tenascin-X (TNX) interacts physically with the small latent TGF-β complex in vitro and in vivo, thus regulating the bioavailability of mature TGF-β to cells by activating the latent cytokine into an active molecule. Activation by the FBG domain most likely occurs through a conformational change in the latent complex and involves a novel cell adhesion–dependent mechanism. We identify α11β1 integrin as a cell surface receptor for TNX and show that this integrin is crucial to elicit FBG-mediated activation of latent TGF-β and subsequent epithelial-to-mesenchymal transition in mammary epithelial cells.

scholarly journals Interaction between sphingosine kinase/sphingosine 1 phosphate and transforming growth factor-β/Smads pathways in experimental intestinal fibrosis. An in vivo immunohistochemical study

2018 ◽  
Author(s):  
Roberta Sferra ◽  
Simona Pompili ◽  
Luca Ventura ◽  
Caroline Dubuquoy ◽  
Silvia Speca ◽  
...  
Keyword(s):  
Growth Factor ◽  
Transforming Growth Factor ◽  
Sphingosine Kinase ◽  
Transforming Growth Factor Β ◽  
Chronic Colitis ◽  
Mesenchymal Transition ◽  
Intestinal Fibrosis ◽  
Sphingosine 1 Phosphate

A concomitant action of multiple profibrotic mediators appears crucial in the development and progression of fibrosis. Sphingosine kinase/sphingosine 1 phosphate and transforming growth factor-β/Smads pathways are both involved in pathogenesis of fibrosis in several organs by controlling differentiation of fibroblasts to myofibroblasts and the epithelial to-mesenchymal transition. However, their direct involvement in chronic colitis-associated fibrosis it is not yet known. In this study we evaluated the immunohistochemical expression of some proteins implicated in sphingosine kinase/sphingosine 1 phosphate and transforming growth factor-β/Smads pathways in Dextrane Sodium Sulphate (DSS)-induced colorectal fibrosis in mice. Compared to control mice, DSS-induced chronic colitis mice developed a marked intestinal fibrosis associated with a concomitant overexpression of TGF-β, p-Smad3, α-SMA, collagen I-III, SPHK1, RhoA, PI3K, Akt, p-Akt, p-mTOR. This study highlights the relationship between the two pathways and the possible role of SPHK1 in the intestinal fibrosis.  These results, if confirmed by in vitro studies, may have important clinical implications in the development of new therapeutical approaches in inflammatory bowel disease.

scholarly journals Estrogen Protects Lenses against Cataract Induced by Transforming Growth Factor-β (TGFβ)

1997 ◽  
Vol 185 (2) ◽  
pp. 273-280 ◽  
Author(s):  
Angela M. Hales ◽  
Coral G. Chamberlain ◽  
Christopher R. Murphy ◽  
John W. McAvoy
Keyword(s):  
Growth Factor ◽  
Transforming Growth Factor ◽  
Hormone Replacement ◽  
Transforming Growth Factor Β ◽  
Epidemiological Studies ◽  
Female Rats ◽  
World Population ◽  
Damaging Effects

Cataract, already a major cause of visual impairment and blindness, is likely to become an increasing problem as the world population ages. In a previous study, we showed that transforming growth factor-β (TGFβ) induces rat lenses in culture to develop opacities and other changes that have many features of human subcapsular cataracts. Here we show that estrogen protects against cataract. Lenses from female rats are more resistant to TGFβ-induced cataract than those from males. Furthermore, lenses from ovariectomized females show increased sensitivity to the damaging effects of TGFβ and estrogen replacement in vivo, or exposure to estrogen in vitro, restores resistance. Sex-dependent and estrogen-related differences in susceptibility to cataract formation, consistent with a protective role for estrogen, have been noted in some epidemiological studies. The present study in the rat indicates that estrogen provides protection against cataract by countering the damaging effects of TGFβ. It also adds to an increasing body of evidence that hormone replacement therapy protects postmenopausal women against various diseases.

Sign in / Sign up

Export Citation Format

Share Document